Research News

A new protein as a target for cancer treatment

Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by Natures Communications and helmed by Associate Professor Polly Chen provides insights into the role of a cancer associated protein, DAP3, in cancer development. Findings in this research article suggests that targeting or blocking the protein DAP3 may hold great promise for cancer treatment.

Read more: https://www.nature.com/articles/s41467-022-29400-7#article-info

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients

This study, led by N2CR members Dr Joline Lim and A/Prof David Tan, looks at the use of next-generation sequencing …

Read More →
Research News

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

Cell cycle dysregulation, a key feature of cancer, leads to excessive cell division. CDK4 and CDK6 are essential for cell …

Read More →
Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. …

Read More →